Targeting <scp>LncRNA</scp>‐Vof16: A Novel Therapeutic Strategy for Neuropathic Pain Relief
Our findings suggest that Vof16 plays a crucial role in maintaining normal sensory function in healthy states and a protective shield against NP following peripheral nerve injury. We therefore propose Vof16 as a new therapeutic target for alleviating NP.
Authors
- Xiaoming Zhao (ORCID: https://orcid.org/0000-0001-7992-1045)
- Xiuying He (ORCID: https://orcid.org/0000-0001-6320-9766)
- Qingjie Xia (ORCID: https://orcid.org/0000-0001-9070-6469)
- Yongquan Zheng (ORCID: https://orcid.org/0000-0002-6091-8265)
- David H. Mauki (ORCID: https://orcid.org/0000-0001-9722-5879)
- Rurong Wang (ORCID: https://orcid.org/0000-0002-1247-1665)
- Ting‐Hua Wang (ORCID: https://orcid.org/0000-0003-2012-8936)
- Shuiping Dai (ORCID: https://orcid.org/0000-0002-9866-6446)
- Huisi Yang
Institutions
- Kunming University of Science and Technology (CN)
- Sichuan University (CN)
- Southwest Medical University (CN)
- West China Hospital of Sichuan University (CN)
- State Key Laboratory of Biotherapy
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/cns.70241
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Sichuan University
- Natural Science Foundation of Sichuan Province